Merck & Co Extend Association with Moderna on New Oncology Programme |
Abstract
pdf
html
|
Keshav Mahawar |
|
Novartis bolsters its immuno-oncology pipeline with Xencor’s bispecific antibodies |
Abstract
pdf
html
|
Natasha Berry |
|
Takeda Bolsters Gastrointestinal Franchise with Acquisition of Ex-US Rights to Cx601 |
Abstract
pdf
html
|
Dan Roberts |
|
Struggling Aegerion and QLT Seek Fresh Start via Merger |
Abstract
html
pdf
|
Subham Nandi & Heather Cartwright |
|
BMS Acquires Cormorant to Expand Immuno-oncology Pipeline |
Abstract
pdf
html
|
Jasmine Kalsi |
|
Juno Turns to Immuno-Oncology Combinations with Acquisition of RedoxTherapies |
Abstract
pdf
html
|
Dan Roberts |
|